These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19042203)

  • 21. Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami.
    Baum MK; Jayaweera DT; Duan R; Sales S; Lai S; Rafie C; Regev A; Page JB; Berkman R; Campa A
    J Addict Dis; 2008; 27(2):37-48. PubMed ID: 18681190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.
    Sundberg I; Lannergård A; Ramklint M; Cunningham JL
    BMC Psychiatry; 2018 May; 18(1):157. PubMed ID: 29843679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in managing HIV in people who use drugs.
    Kamarulzaman A; Altice FL
    Curr Opin Infect Dis; 2015 Feb; 28(1):10-6. PubMed ID: 25490106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV-HIV coinfection: simple messages from a complex disease.
    Klenerman P; Kim A
    PLoS Med; 2007 Oct; 4(10):e240. PubMed ID: 17927445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus and human immunodeficiency virus co-infection in women.
    Orenstein R; Tsogas N
    J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 2):S1-6. PubMed ID: 11794748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UNITAID can address HCV/HIV co-infection.
    von Schoen-Angerer T; Cohn J; Swan T; Piot P
    Lancet; 2013 Feb; 381(9867):628. PubMed ID: 23439101
    [No Abstract]   [Full Text] [Related]  

  • 29. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Co-infection with HIV-hepatitis C virus].
    Bertholom C
    Rev Infirm; 2005 Oct; (114):27-8. PubMed ID: 16359042
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
    Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
    Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.
    Mwatelah RS; Lwembe RM; Osman S; Ogutu BR; Aman R; Kitawi RC; Wangai LN; Oloo FA; Kokwaro GO; Ochieng W
    PLoS One; 2015; 10(7):e0132287. PubMed ID: 26208212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of drug abuse in Germany and China.
    Michels II; Fang YX; Zhao D; Zhao LY; Lu L
    Acta Pharmacol Sin; 2007 Oct; 28(10):1505-18. PubMed ID: 17883935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C and HIV co-infection: a review.
    Maier I; Wu GY
    World J Gastroenterol; 2002 Aug; 8(4):577-9. PubMed ID: 12174359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications.
    Bednasz CJ; Venuto CS; Ma Q; Morse GD
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):135-139. PubMed ID: 28263465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies.
    Tedaldi EM
    J Addict Dis; 2008; 27(2):83-91. PubMed ID: 18681195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.
    Hansen AB; Lohse N; Gerstoft J; Kronborg G; Laursen A; Pedersen C; Sørensen HT; Obel N
    PLoS One; 2007 Aug; 2(8):e738. PubMed ID: 17710138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.
    Li MD; Hser YI; Chen Z; Chang L
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):379-82. PubMed ID: 27484319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.